ARCHIVES

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

This article is from The Cancer Letter archive.

Vol. 33 No. 16 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Holleb To Retire In June As ACS Vice President; Consensus Conference On Neurofibromatosis Set

January 23, 1987

ORI Instructs NSAB to Prepare for Investigation

April 19, 1996

National Action Plan: Return $14 Million To NCI, Committee Tells Shalala

February 14, 1997

Adamson, Henney Chair Silicone Task Force

April 25, 1992

Advisors Approve Program To Link Radiation Oncologists.

June 29, 2001

Moloney Out As Viral Oncology Chief, Names “Acting Assistant Director” Of NCI By Upton

January 6, 1978